These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7248993)

  • 1. Phase II trial of 5-FU melphalan in advanced colorectal carcinoma.
    Gough IR; Furnival CM; Thynne GS; Burnett W
    Cancer Treat Rep; 1981; 65(7-8):735-6. PubMed ID: 7248993
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose intermittent iv 5-FU and melphalan in advanced colorectal carcinoma.
    Gough IR; Furnival CM
    Cancer Treat Rep; 1983 Jun; 67(6):595-6. PubMed ID: 6344994
    [No Abstract]   [Full Text] [Related]  

  • 3. Melphalan, vincristine, and 5-FU in advanced colonic carcinoma: results of a pilot study.
    Ashenhurst J; Bitran JD; Robin E; Desser RK; Shapiro C; Kozloff MF; Billings AA
    Cancer Treat Rep; 1981; 65(9-10):869-72. PubMed ID: 7273020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of 5-fluorouracil plus melphalan in colorectal carcinoma.
    Presant CA; Ratkin G; Klahr C
    Cancer Treat Rep; 1978 Mar; 62(3):461-2. PubMed ID: 348317
    [No Abstract]   [Full Text] [Related]  

  • 5. 5-FU, methotrexate, and mitomycin in advanced colorectal adenocarcinoma: a phase II study.
    Biran H; Sulkes A; Biran S
    Cancer Treat Rep; 1981; 65(9-10):924-5. PubMed ID: 7273031
    [No Abstract]   [Full Text] [Related]  

  • 6. Thymidine and 5-FU: a Phase II pilot study in colorectal and breast carcinomas.
    Presant CA; Multhauf P; Klein L; Chan C; Chang FF; Hum G; Joseph R; Opfell R; Lemkin S; Shiftan T; Plotkin D
    Cancer Treat Rep; 1983; 67(7-8):735-6. PubMed ID: 6871891
    [No Abstract]   [Full Text] [Related]  

  • 7. Preliminary report of a clinical trial of the treatment of patients with advanced stage III and IV ovarian cancer with melphalan, 5-fluorouracil, and methotrexate in combination and sequentially: a study of the Clinical Trials Group of the National Cancer Institute of Canada.
    Klaassen DJ; Boyes DA; Gerulath A; Levitt M; Miller AB; Pearson JG
    Cancer Treat Rep; 1979 Feb; 63(2):289-95. PubMed ID: 376135
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy for advanced colorectal cancer with a combination of 5-FU and anguidine: a Southwest Oncology Group Study.
    Goodwin W; Stephens R; McCracken JD; Groppe C
    Cancer Treat Rep; 1981; 65(3-4):359. PubMed ID: 7237462
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II trial: mitomycin c and methotrexate combination therapy for advanced colorectal carcinoma.
    Budman DR; Schulman P; Vinciguerra V; Degnan T
    Cancer Treat Rep; 1981; 65(5-6):535. PubMed ID: 7237477
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination chemotherapy of continuous infusion 5-FU and daily low-dose CDDP in colorectal carcinoma].
    Furuhata T; Hirata K; Yamamitsu S; Kimura H; Sasaki K; Hata F; Shirasaka T
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1554-8. PubMed ID: 10553412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
    Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
    Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of bisantrene in advanced colorectal carcinoma.
    Ahmed T; Kemeny NE; Michaelson RA; Harper HD
    Cancer Treat Rep; 1983 Mar; 67(3):307-8. PubMed ID: 6831479
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase I trial of sulindac plus 5-fluorouracil and levamisole: potential adjuvant therapy for colon carcinoma.
    Sinicrope FA; Pazdur R; Levin B
    Clin Cancer Res; 1996 Jan; 2(1):37-41. PubMed ID: 9816087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of 4-demethoxydaunorubicin in advanced colorectal carcinoma.
    Harper HD; Kemeny NE; Ahmed T; Cheng E; Arena F; Sordillo P; Faye L
    Cancer Treat Rep; 1984 Apr; 68(4):689-90. PubMed ID: 6585273
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic implications of c-Ki-ras2 mutations in patients with advanced colorectal cancer treated with 5-fluorouracil and interferon: a study of the eastern cooperative oncology group (EST 2292).
    Wadler S; Bajaj R; Neuberg D; Agarwal V; Haynes H; Benson AB
    Cancer J Sci Am; 1997; 3(5):284-8. PubMed ID: 9327152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764).
    Shaw MT; Bonnet JD; Wilson H; Heilbrun LK
    Cancer Treat Rep; 1980; 64(2-3):247-50. PubMed ID: 7407758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon.
    Czito BG; Hong TJ; Cohen DP; Tyler DS; Lee CG; Anscher MS; Ludwig KA; Seigler HF; Mantyh C; Morse MA; Lockhart AC; Petros WP; Honeycutt W; Spector NL; Ertel PJ; Mangum SG; Hurwitz HI
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):779-85. PubMed ID: 14967434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
    Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
    Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
    Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
    J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS).
    James RD; Donaldson D; Gray R; Northover JM; Stenning SP; Taylor I;
    Br J Surg; 2003 Oct; 90(10):1200-12. PubMed ID: 14515287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.